PET/MRI imaging

DEVICE2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham

Conditions

Breast CancerCervical CancerEndometrial Cancer

Early Phase 1

Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

RecruitingNCT03321045

University of Alabama at BirminghamBreast Cancer

Start: 2017-11-21End: 2028-10-01Target: 10Updated: 2026-01-26

Phase 1

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Active, not recruitingNCT02285192

Memorial Sloan Kettering Cancer CenterCervical Cancer, Endometrial Cancer

Start: 2014-11-30End: 2026-11-30Updated: 2025-12-30

Related Papers

Positron Lymphography via Intracervical <sup>18</sup>F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies

Journal of Nuclear Medicine2020-01-1012 citations